Mikkelsen, S U, Kjær, L, Bjørn, M E, Knudsen, T A, Sørensen, A L, Skov, V, Andersen, C B L, Weiss Bjerrum, O, Brochmann Mortensen, N, El Fassi, D, Kruse, T A, Larsen, T S, Mourits-Andersen, H T, Nielsen, C H, Pallisgaard, N, Thomassen, M & Hasselbalch, H C 2018, ' Safety And Efficacy Of Combination Therapy Of Interferon Αlpha-2 And Ruxolitinib In Polycythemia Vera And Low-/Intermediate-1-Risk Myelofibrosis – A One Year Follow-Up Update Of A Phase II Study ', European Hematology Association 23rd congress EHA 2018, Stockholm, Sweden, 14/06/2018-17/06/2018 . Mikkelsen, S U, Kjær, L, Bjørn, M E, Knudsen, T A, Sørensen, A L, Skov, V, Andersen, C B L, Weiss Bjerrum, O, Brochmann Mortensen, N, El Fassi, D, Kruse, T A, Larsen, T S, Mourits-Andersen, H T, Nielsen, C H, Pallisgaard, N, Thomassen, M & Hasselbalch, H C 2018, ' SAFETY AND EFFICACY OF COMBINATION THERAPY OF INTERFERON ΑLPHA-2 AND RUXOLITINIB IN POLYCYTHEMIA VERA AND LOW-/INTERMEDIATE-1-RISK MYELOFIBROSIS – A ONE YEAR FOLLOW-UP UPDATE OF A PHASE II STUDY ', EHA Learning Center, vol. 2018, PF620 . < http://learningcenter.ehaweb.org/eha/2018/stockholm/215880/stine.mikkelsen.safety.and.efficacy.of.combination.therapy.of.interferon.html >